Global Contraceptive Pills Market - Growth, Trends, and Forecast (2019 - 2024)

The Market is segmented by Hormone Type (Progestin Pills and Combination Pills), Category and Geography

Market Snapshot

con 1
Study Period:

2016-2024

Base Year:

2018

Fastest Growing Market:

Asia Pacific

Largest Market:

North America

CAGR:

9%

Key Players:

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Market Overview

Unwanted pregnancies are on the rise, globally. Government bodies of various countries have been taking measures, like promoting the use of contraceptive pills to prevent this unwanted growth. It is estimated that among the number of pregnancies that occur in the United States, nearly 76% of them are unwanted and are under the age of 30. According to Harvard researchers, it is estimated that single parenthood due to unwanted pregnancies is the reason for holding out on economic mobility, more than other variables like education and race. According to the data published in the Medical Journal of Australia, it has been estimated that almost half of all the pregnancies in Australia are unplanned. A survey published in the Medical Journal of Australia in 2018, has found that of the 1390 women who reported pregnancies over 10 years, more than a quarter (362) said they had an unintended pregnancy, including 94 who said their pregnancies were unwanted. Given the widespread implications of unwanted pregnancies, the market for contraceptive pills is expected to experience a surge during the forecast period.

Scope of the Report

As per the scope of the report, contraceptive pills are a kind of medicine with hormones, which generally come in a pack. The pills are affordable, effective, and has other health benefits. The contraceptive pill works by stopping sperm from joining with an egg during fertilization. The hormones in the pill stop ovulation. Furthermore, pill’s hormones also thicken the mucus on the cervix. This thicker cervical mucus blocks sperm. 

By Hormone Type
Progestin Pills
Combination Pills
Monophasic
Triphasic
Other Combination Pills
By Category
Generic
Branded
Geography
North America
US
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Generic Oral Contraceptive is Expected to Hold Largest Share of Global Contraceptive Pills Market, Over the forecast period

Generic Oral Contraceptive has the largest share in the market due to the widespread adoption of generic contraceptives facilitated by their low prices and ease of use. Furthermore, the increasing need for population control and the increasing incident of abortion has driven the growth of the generic contraceptive pills in the market. A dramatic increase in the number of different birth control pills available in the United States resulted from the Drug Price Competition and Patent Term Restoration Act of 1984, also known as the “Hatch-Waxman Act,” which set up the modern system of generic drug approval and regulation. Physicians, pharmacists, and women could choose pills based on price because the action of these contraceptives, or their therapeutic equivalence, was essentially the same. Brand-name manufacturers are finding a way to make their products stand out from the generic crowd. Thus all these initiatives will propel the growth of the market in the forecast period. 

Con 2

To understand key trends, Download Sample Report

North America Region Holds the Largest Market Share of Contraceptive Pills Market

North America dominates the Contraceptive Pills market, owing to rapid developments in healthcare infrastructure and high awareness. There were approximately 60 million women in the United States in their child-bearing years (age 15 - 44), as of 2017. Around 70% of these women were at risk of unintended pregnancy. More than 99% of women aged between 15 - 44 years have used at least one contraceptive method. This indicates the high awareness and demand for avoiding unintended pregnancies in the United States. Thus use of contraceptive pills accounts for largest expenditure on contraceptive methods in the United States.

Con 3

To understand geography trends, Download Sample Report

Competitive Landscape

The market competition is set to intensify as several key players are focusing on expansion of their Contraceptive Pills portfolio through acquisition and collaboration with companies. The Contraceptive Pills market is expected to open up several opportunities for new players as well as currently established market leaders. The key players in the market include Bayer Healthcare, Amgen Inc., Baxter, Gilead Sciences Inc., GlaxoSmithKline PLC, amongst others.

Major Players

  1. Bayer Healthcare
  2. Amgen Inc.
  3. Baxter
  4. Merck & Co. Inc.
  5. GlaxoSmithKline PLC

* Complete list of players covered available in the table of contents below

Con 4

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Awareness about Contraceptive Pills

      2. 4.2.2 Need to Prevent Unwanted Abortions

      3. 4.2.3 Ease of Use and Low Cost

    3. 4.3 Market Restraints

      1. 4.3.1 Side Effects Associated with the Use of Contraceptive Drugs

      2. 4.3.2 Increased Usage of Alternative Birth Control Method

    4. 4.4 Porte's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Hormone Type

      1. 5.1.1 Progestin Pills

      2. 5.1.2 Combination Pills

        1. 5.1.2.1 Monophasic

        2. 5.1.2.2 Triphasic

        3. 5.1.2.3 Other Combination Pills

    2. 5.2 By Category

      1. 5.2.1 Generic

      2. 5.2.2 Branded

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 US

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 UK

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Bayer Healthcare

      2. 6.1.2 Amgen Inc.

      3. 6.1.3 Baxter

      4. 6.1.4 Gilead Sciences Inc.

      5. 6.1.5 GlaxoSmithKline PLC

      6. 6.1.6 Johnson & Johnson

      7. 6.1.7 Merck & Co. Inc.

      8. 6.1.8 Novartis AG

      9. 6.1.9 Pfizer Inc.

      10. 6.1.10 Sanofi

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please Enter a Valid Message!


Complete your payment details below

Shipping & Billing Information

Payment Information